Position in RLMD
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$156,196
-$4,073,153 QoQ
Shares Held
22,442
-80.4% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RLMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $8,191,566,293 across 258 Biotechnology names. RLMD ranks #224 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,724,478 | $1,332,400,669 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,561,057 | $1,143,614,384 | |
| 3 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,291,726 | $427,393,371 | |
| 5 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 7 | INSM |
INSMED Inc
|
1,988,968 | $325,236,040 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in RLMD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $156,196 | 22,442 | Shares | Defined | 2026-05-12 | |
| 2022-09-30 | $4,229,349 | 114,245 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $202,564 | 10,667 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $246,202 | 9,122 | Shares | Defined | 2022-05-16 | |
| 2020-12-31 | $8,567,660 | 267,155 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $9,967,982 | 264,965 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $14,442,659 | 322,741 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $9,077,284 | 266,118 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||